ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported a loss of $1.9 million in its third quarter.
On a per-share basis, the Alachua, Florida-based company said it had a loss of 4 cents. Earnings, adjusted for stock option expense, were 7 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.
The regenerative medicine company posted revenue of $48.6 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $47 million.
AxoGen expects full-year revenue in the range of $182 million to $186 million.
AxoGen shares have more than doubled since the beginning of the year. The stock has nearly quadrupled in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.